SHUKRA PHARMACEUTICALS
|
The Current P/S Ratio of SHUKRA PHARMACEUTICALS is 66.47.
| Share Price | ₹53.3 | Dec 23,2025 |
| Market Cap | ₹2,334.4 Cr | |
| Sales-TTM | ₹35.1 Cr | TTM-Standalone Results |
| Price/Sales | 66.47x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of SHUKRA PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹2,334.4 Cr] as on Dec 23,2025
(/) Sales [ ₹35.1 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 66.47x ]
Thus, for SHUKRA PHARMACEUTICALS , the investors are currently willing to pay '66.47 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SHUKRA PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of SHUKRA PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of SHUKRA PHARMACEUTICALS
PS Ratio Performance Analysis for SHUKRA PHARMACEUTICALS
- SHUKRA PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 7.11x.
- SHUKRA PHARMACEUTICALS 's operated at median p/e ratio of 0.62x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SHUKRA PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 29.36x.
- SHUKRA PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2023 of 0.31x.
How does SHUKRA PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| SHUKRA PHARMACEUTICALS | 35.1 | 66.47 | 2,334.4 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.66 | 421,131.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 17.14 | 171,862.0 |
| CIPLA LTD | 28,349.6 | 4.28 | 121,198.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 10.55 | 129,254.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 3.12 | 107,083.0 |
| MANKIND PHARMA LTD | 13,576.9 | 6.78 | 92,070.0 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.81 | 93,388.6 |
| LUPIN LTD | 24,750.7 | 3.90 | 96,535.3 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.17 | 70,671.9 |
| ABBOTT INDIA LTD | 6,714.4 | 8.97 | 60,221.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SHUKRA PHARMACEUTICALS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.17x |
| Max industry PS | 66.47x |
| Median industry PS | 6.78x |
| Average industry PS | 12.26x |
You may also like the below Video Courses